Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 AUD | +11.11% | -13.04% | -45.95% |
29/02 | Radiopharm Theranostics Doses First Patient in Pancreatic Cancer Imaging Study | MT |
29/02 | Radiopharm Theranostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.95% | 11.95M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- RAD Stock
- News Radiopharm Theranostics Limited
- Radiopharm Theranostics Acquiring Three Patents for Solid Tumor Diagnostics